Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CXA-201

- PMLiVE

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

Becomes the first new drug to treat the condition in over 15 years

- PMLiVE

Pharma must do more on antibiotic resistance, Davos meeting hears

But AMR report acknowledges the industry is doing 'better than expected'

Can Cinderella save us?

AMR research ‘under threat’ due to lack of economic incentives

But industry report also shows progress made by the private sector

Can Cinderella save us?

Motif Bio preps US filing after antibiotic clears phase III

The UK biopharma hopes to launch iclaprim by early 2019

- PMLiVE

Shake-up at GSK could claim antibiotics unit and UK facilities

The firm says its plans, which are expected to lead to 320 job cuts, are not related to Brexit

- PMLiVE

Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses

The not-for-profit app is a collaboration between Oxford PharmaGenesis and Global Initiative

- PMLiVE

Pfizer launches antibiotic resistance surveillance website

Designed for healthcare professional use ATLAS will cover 60 countries

- PMLiVE

Longitude Prize awards grants for antibiotic test development

Five UK teams among the winners seeking to tackle antimicrobial resistance

- PMLiVE

ROAD Comms wins antimicrobial resistance account

Selected by GAMA Healthcare to create infection control campaign

AstraZeneca AZ global R&D corporate HQ

AZ slims down again with sale of antibiotics to Pfizer

Deal does not include biologic anti-infective products from Medimmune unit

- PMLiVE

Merck starts pivotal trials of new antibiotic combination

Continues testing after positive phase II results for relebactam addition 

AstraZeneca AZ

CHMP backs AZ’s ‘superbug’ antibiotic product

Zavicefta recommended for European approval

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links